Related Experiment Video
Updated: Jun 4, 2026
05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
TLRs, Alcohol, HCV, and Tumorigenesis
1Department of Molecular Microbiology and Immunology, 503B-HMR, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.
Gastroenterology Research and Practice
|February 19, 2011
Summary
Hepatitis C virus (HCV) and alcoholic liver diseases (ALD) synergize to increase hepatocellular carcinoma (HCC) risk. This interaction may promote liver cancer through Toll-like receptor (TLR) signaling pathways and cancer-initiating stem cells (CSCs).
Area of Science:
- Hepatology
- Oncology
- Immunology
Background:
- Chronic liver damage from viral infections, alcohol, or obesity elevates hepatocellular carcinoma (HCC) risk.
- Hepatitis C virus (HCV) and alcoholic liver diseases (ALD) exhibit significant synergistic effects.
- Toll-like receptor (TLR) signaling is upregulated in chronic liver diseases, and alcoholism is linked to endotoxemia-driven inflammation.
Purpose of the Study:
- To investigate the synergistic mechanisms between HCV and ALD in promoting liver cancer.
- To explore the role of Toll-like receptor (TLR) signaling in alcohol- and HCV-induced liver tumorigenesis.
- To understand the contribution of cancer-initiating stem cells (CSCs) in the context of combined HCV and ALD exposure.
Main Methods:
- Review of epidemiological evidence on HCV and ALD synergism.
- Analysis of studies on TLR signaling pathways in chronic liver disease.
- Examination of research on cancer-initiating stem cells (CSCs) in HCC.
Main Results:
- Strong epidemiological evidence supports a synergistic relationship between HCV and ALD.
- TLR signaling pathways are upregulated in chronic liver diseases.
- Alcoholism-induced endotoxemia contributes to liver inflammation.
Conclusions:
- The combined effects of alcohol and HCV may drive liver tumorigenesis.
- TLR signaling is a potential key pathway mediating this synergistic effect.
- Further research into CSCs and TLRs is warranted for understanding HCC development in this context.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...